Social Media Ideas for Glp-1 Telemedicine

Telehealth Booms As Demand For GLP-1s Surges and Questions Mount About Safety, Oversight

WEDNESDAY, JUNE 3, 2026 — Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was adm...

Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight

Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded. Meanwhile, researchers and doctors are concerned that...

Telehealth is Making GLP-1s More Accessible – But Access Alone isn’t Enough

Providing access to GLP-1s only solves part of the problem. In fact, without a broader approach, it may lead to new challenges alongside the ones it aims to address. The post Teleh...

Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight

Some medical experts are concerned that virtual care may be insufficient for prescribing weight loss drugs. The post Telehealth Booms as Demand for GLP-1s Surges and Questions Moun...

GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing

TUESDAY, July 7, 2026 — Getting a GLP-1 prescription online can be quick and convenient, but new research suggests it may come with surprisingly little medical oversight. Ashwin Ch...

Telehealth booms as demand for GLP-1s surges and questions mount about safety, oversight

Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, Karleigh McClain was admitted to the hospital, she...

GLP-1 Benefits Are Growing Fast: The Follow-Up Problem Nobody Talks About

GLP-1 medications and hormone therapies have moved from niche to mainstream. About 19% of large employers now cover GLP-1 drugs used primarily for weight loss, according to the Kai...

Zevay GLP-1 Review 2026: Could This Lower-Cost Telehealth Option Be the Right Fit for Your Weight-Management Goals?

As more adults compare convenient and potentially more affordable GLP-1 care in 2026, this Zevay review explores advertised semaglutide and tirzepatide pricing, online provider eva...

VivioMD GLP-1 Program Overview 2026: Semaglutide, Tirzepatide, Pricing, Safety and Refund Terms Investigated

As more consumers seek structured, provider-guided weight management support in 2026, this VivioMD GLP-1 review explores the platform's advertised care experience, treatment-access...

GLP-1 use confers benefits in obesity, autoimmune disease

NEW ORLEANS — Individuals with obesity and autoimmune diseases who use a GLP-1 receptor agonist may have lower risk for mortality, fewer cardiovascular and thrombotic events and lo...

The GLP-1 Microdosing Trend Patients Are Whispering About: California Trim Clinic Explains Why Low-Dose Tirzepatide Is S...

Tirzepatide microdosing is becoming the GLP-1 conversation patients are having after the weight loss headline fades. As more patients reach goal weight, battle side effects, or loo...

<![CDATA[Pharmaceutical Executive Daily: The Medicare GLP-1 Bridge]]>

<![CDATA[Educating Patients About GLP-1s: Q&A with Kristen Hartzell, PharmD]]>

Medicare launches pilot program expanding access to GLP-1 drugs

The program's demonstration run will last from July 1, 2026, until December 31, 2027, Medicare said.

Samsung and Massachusetts General Hospital Launch Joint Study To Investigate GLP-1 Treatment Monitoring With Galaxy Watc...

Samsung Electronics and Massachusetts General Hospital (MGH) Diabetes Research Center (DRC) today jointly announced a research study to investigate the efficacy of Galaxy Watch in...

Lenz Therapeutics rolls out telehealth offering for Vizz prescription eye drops

A patient-driven telehealth Rx model is more sustainable given the success of other aesthetic Rx products offered via telehealth, including GLP-1s and acne medications, Leerink Par...

Medicare launches pilot program expanding access to GLP-1 drugs

The program's demonstration run will last from July 1, 2026, until December 31, 2027, Medicare said.

What to know about the temporary Medicare GLP-1 Bridge program

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half t...

What is the Medicare GLP-1 Bridge program?

As our understanding of obesity as a chronic disease has evolved, one paradox has been the ongoing barriers to accessing effective therapeutics for this condition, an approach vast...

Medicare launches pilot program expanding access to GLP-1 drugs

The program's demonstration run will last from July 1, 2026, until December 31, 2027, Medicare said.

What to know about the temporary Medicare GLP-1 Bridge program

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half t...

Medicare launches pilot program expanding access to GLP-1 drugs

The program's demonstration run will last from July 1, 2026, until December 31, 2027, Medicare said.

GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs

THURSDAY, July 9, 2026 — The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. That’s about 40 million people — as many folks who live in Calif...

Looking at the impact of GLP-1s on the fitness industry

The different medications work to help regulate appetite and blood sugar levels.